New perspectives for T-cell-based HCV vaccines

Rehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection, Nat Rev Immunol, 5, 215, 10.1038/nri1573 Bertoletti, 2003, Kinetics of the immune response during HBV and HCV infection, Hepatology, 38, 4, 10.1053/jhep.2003.50310 Wieland, 2005, Stealth and Cunning: hepatitis B and hepatitis C viruses, J Virol, 79, 9369, 10.1128/JVI.79.15.9369-9380.2005 Folgori, 2006, A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nat Med, 12, 190, 10.1038/nm1353 Bartosch, 2003, J Exp Med, 197, 633, 10.1084/jem.20021756 Hsu, 2003, Proc Natl Acad Sci USA, 100, 7271, 10.1073/pnas.0832180100 Logvinoff, 2004, Proc Natl Acad Sci USA, 101, 10149, 10.1073/pnas.0403519101 Lavillette, 2005, Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection, J Virol, 79, 6023, 10.1128/JVI.79.10.6023-6034.2005 Bartosch, 2005, An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies, J Virol, 79, 8217, 10.1128/JVI.79.13.8217-8229.2005 Forns, 2000, Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV, Hepatology, 32, 618, 10.1053/jhep.2000.9877 Rollier, 2004, Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response, J Virol, 78, 187, 10.1128/JVI.78.1.187-196.2004 Puig, 2004, Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection, Vaccine, 22, 991, 10.1016/j.vaccine.2003.09.010